Which funds bought or sold VRTX in Q3 2026?
Vertex Pharmaceuticals Inc. 5 funds bought, 6 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$701M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Jennison+$300M
- Citadel+$273M
- CPP Investments+$100M
- Northern Trust+$41M
- CalPERS+$20M
- Capital Research−$876M
- JPMorgan−$435M
- Ameriprise−$178M
- Schwab−$86M
- Adage−$67M
- Hudson Bay−$61M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (5)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Jennison Growth / crossover | Added+19.2% | +$300M | $1.9B |
| Citadel Quant & multi-strategy | Added+102.3% | +$273M | $540M |
| CPP Investments Sovereign & pension | Added+53.9% | +$100M | $286M |
| Northern Trust Bank & broker | Added+3.2% | +$41M | $1.3B |
| CalPERS Sovereign & pension | Added+8.4% | +$20M | $254M |
Sold (6)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Capital Research Asset manager | Trimmed-8.6% | −$876M | $9.3B |
| JPMorgan Bank & broker | Trimmed-12.7% | −$435M | $3.0B |
| Ameriprise Asset manager | Trimmed-13.1% | −$178M | $1.2B |
| Schwab Index giant | Trimmed-8.1% | −$86M | $981M |
| Adage Hedge fund | Trimmed-32.4% | −$67M | $139M |
| Hudson Bay Quant & multi-strategy | Trimmed-29.8% | −$61M | $143M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.